Comparison

Ritlecitinib European Partner

Manufacturer TargetMol
Category
Type Inhibitor
Specific against other
Amount 200mg
Item no. TMO-T5382-200mg
CASRN 1792180-81-4
eClass 6.1 30220300
eClass 9.0 32160605
Available
Short Description
Ritlecitinib (PF-06651600) is a potent JAK3-selective inhibitor (IC50: 33.1 nM).
Shipping
cool pack
Storage
-20°
Target names or alias
PF-06651600
Molecular Weight
285, 34
Pathway
Stem Cells|||JAK/STAT signaling|||Chromatin/Epigenetic|||Angiogenesis
Target
JAK

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200mg
Available: In stock
available

Delivery expected until 5/23/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close